Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021			107,509,096
Beginning balance at Dec. 31, 2021	$ 596,593	$ (22,147)	$ 108	$ 1,018,005	$ (30,794)	$ 6,083	$ (427,603)	$ 8,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	35,998			35,998
Common stock issued under employee stock plans (in shares)			2,057,101
Common stock issued under employee stock plans	6,111		$ 2	6,109
Taxes paid related to net share settlement of equity awards	(28,825)			(28,825)
Unrealized loss on derivative instruments, net of tax	(3,179)					(3,179)
Unrealized income (loss) on available for sale securities, net of tax	(10)					(10)
Net loss	(48,763)						(48,763)
Ending balance (in shares) at Mar. 31, 2022			109,566,197
Ending balance at Mar. 31, 2022	535,778		$ 110	1,000,493		2,894	(467,719)
Beginning balance (in shares) at Dec. 31, 2021			107,509,096
Beginning balance at Dec. 31, 2021	596,593	$ (22,147)	$ 108	1,018,005	$ (30,794)	6,083	(427,603)	$ 8,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized loss on derivative instruments, net of tax	(18,423)
Unrealized income (loss) on available for sale securities, net of tax	(17)
Net loss	(113,770)
Ending balance (in shares) at Sep. 30, 2022			110,213,856
Ending balance at Sep. 30, 2022	532,307		$ 110	1,077,280		(12,357)	(532,726)
Beginning balance (in shares) at Mar. 31, 2022			109,566,197
Beginning balance at Mar. 31, 2022	535,778		$ 110	1,000,493		2,894	(467,719)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	37,758			37,758
Common stock issued under employee stock plans (in shares)			320,000
Common stock issued under employee stock plans	5		$ 0	5
Taxes paid related to net share settlement of equity awards	(6)			(6)
Unrealized loss on derivative instruments, net of tax	(10,804)					(10,804)
Unrealized income (loss) on available for sale securities, net of tax	(9)					(9)
Net loss	(36,290)						(36,290)
Ending balance (in shares) at Jun. 30, 2022			109,886,197
Ending balance at Jun. 30, 2022	526,432		$ 110	1,038,250		(7,919)	(504,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	34,300			34,300
Common stock issued under employee stock plans (in shares)			327,659
Common stock issued under employee stock plans	5,393		$ 0	5,393
Taxes paid related to net share settlement of equity awards	(663)			(663)
Unrealized loss on derivative instruments, net of tax	(4,440)					(4,440)
Unrealized income (loss) on available for sale securities, net of tax	2					2
Net loss	(28,717)						(28,717)
Ending balance (in shares) at Sep. 30, 2022			110,213,856
Ending balance at Sep. 30, 2022	$ 532,307		$ 110	1,077,280		(12,357)	(532,726)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(4,415,093)
Repurchase of common stock	$ (99,967)
Ending balance (in shares) at Sep. 30, 2023			108,953,058
Ending balance at Sep. 30, 2023	444,573		$ 109	1,111,076		(23,120)	(643,492)
Beginning balance (in shares) at Dec. 31, 2022			107,673,052
Beginning balance at Dec. 31, 2022	502,125		$ 108	1,055,048		(9,557)	(543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	35,811			35,811
Common stock issued under employee stock plans (in shares)			2,218,811
Common stock issued under employee stock plans	5,853		$ 2	5,851
Taxes paid related to net share settlement of equity awards	(16,864)			(16,864)
Repurchase of common stock (in shares)			(100,000)
Repurchase of common stock	(2,519)		$ 0	(2,519)
Unrealized loss on derivative instruments, net of tax	(4,980)					(4,980)
Unrealized income (loss) on available for sale securities, net of tax	156					156
Net loss	(38,304)						(38,304)
Ending balance (in shares) at Mar. 31, 2023			109,791,863
Ending balance at Mar. 31, 2023	481,278		$ 110	1,077,327		(14,381)	(581,778)
Beginning balance (in shares) at Dec. 31, 2022			107,673,052
Beginning balance at Dec. 31, 2022	502,125		$ 108	1,055,048		(9,557)	(543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized loss on derivative instruments, net of tax	(13,012)
Unrealized income (loss) on available for sale securities, net of tax	(551)
Net loss	(100,018)
Ending balance (in shares) at Sep. 30, 2023			108,953,058
Ending balance at Sep. 30, 2023	444,573		$ 109	1,111,076		(23,120)	(643,492)
Beginning balance (in shares) at Mar. 31, 2023			109,791,863
Beginning balance at Mar. 31, 2023	481,278		$ 110	1,077,327		(14,381)	(581,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	39,385			39,385
Common stock issued under employee stock plans (in shares)			233,974
Common stock issued under employee stock plans	36		$ 0	36
Taxes paid related to net share settlement of equity awards	(2,575)			(2,575)
Repurchase of common stock (in shares)			(207,278)
Repurchase of common stock	(5,080)		$ 0	(5,080)
Unrealized loss on derivative instruments, net of tax	(2,991)					(2,991)
Unrealized income (loss) on available for sale securities, net of tax	(647)					(647)
Net loss	(38,697)						(38,697)
Ending balance (in shares) at Jun. 30, 2023			109,818,559
Ending balance at Jun. 30, 2023	470,709		$ 110	1,109,093		(18,019)	(620,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,980			32,980
Common stock issued under employee stock plans (in shares)			327,868
Common stock issued under employee stock plans	5,457		$ 0	5,457
Taxes paid related to net share settlement of equity awards	(532)			(532)
Repurchase of common stock (in shares)			(1,193,369)
Repurchase of common stock	(35,923)		$ (1)	(35,922)
Unrealized loss on derivative instruments, net of tax	(5,041)					(5,041)
Unrealized income (loss) on available for sale securities, net of tax	(60)					(60)
Net loss	(23,017)						(23,017)
Ending balance (in shares) at Sep. 30, 2023			108,953,058
Ending balance at Sep. 30, 2023	$ 444,573		$ 109	$ 1,111,076		$ (23,120)	$ (643,492)